Guideline of transthyretin-related hereditary amyloidosis for clinicians
Yukio Ando, Teresa Coelho, John L. Berk, Márcia Waddington‐Cruz, Bo‐Göran Ericzon, Shu-ichi Ikeda, William David Lewis, Laura Piera Obici, Violaine Planté‐Bordeneuve, Claudio Rapezzi, Gérard Saïd, Fabrizio Salvi · 2013
Read Guideline of transthyretin-related hereditary amyloidosis for clinicians by Yukio Ando, Teresa Coelho, John L. Berk, Márcia Waddington‐Cruz, Bo‐Göran Ericzon, Shu-ichi Ikeda, William David Lewis, Laura Piera Obici, Violaine Planté‐Bordeneuve, Claudio Rapezzi, Gérard Saïd, Fabrizio Salvi (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w2115862827.txt.
Description
Yukio Ando, Teresa Coelho, John Berk and colleagues wrote a clinician's guide to a hereditary amyloid disease. Their paper appeared in Orphanet Journal of Rare Diseases in 2013. The disease slowly damages nerves and the heart. Faulty transthyretin protein forms harmful deposits. Its varied symptoms make it hard to recognise.
Misdiagnosis is common in this condition. Patients may wait years for the right answer. The guide explains how to confirm the diagnosis. It covers staging and tracking of progression. Symptom relief options are reviewed in detail. Liver transplant and newer drugs are discussed. Some drug treatments showed promise in trials. Early recognition can slow irreversible decline.
Catalog record
| CREATOR | Yukio Ando, Teresa Coelho, John L. Berk, Márcia Waddington‐Cruz, Bo‐Göran Ericzon, Shu-ichi Ikeda, William David Lewis, Laura Piera Obici, Violaine Planté‐Bordeneuve, Claudio Rapezzi, Gérard Saïd, Fabrizio Salvi |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 97 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Orphanet Journal of Rare Diseases |